Paris, France

Francoise Roquet

This inventor holds 1 USPTO granted patent. Top assignee: Laboratoire Roger Bellon. Active years: 1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francoise Roquet. Retrieved from https://idiyas.com/inventor/francoise-roquet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Francoise Roquet

Introduction

Francoise Roquet is a notable inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. Her work is particularly focused on addressing critical health issues such as asthma and premature labor.

Latest Patents

Francoise Roquet holds a patent for novel compounds with .beta.-adrenergic properties. The patent describes the compound 1-[1-benzimidazolyl] N-[2-(4-hydroxy 3-methoxy phenyl) 2-hydroxy ethyl]3-amino butane, along with its addition salts with pharmaceutically acceptable non-toxic inorganic or organic acids, and the hydrates of said salts. These compounds are particularly useful for the treatment of asthma and in the case of premature labor. She has 1 patent to her name.

Career Highlights

Roquet is associated with Laboratoire Roger Bellon, where she has been able to apply her innovative ideas in a practical setting. Her work has contributed to advancements in pharmaceutical research and development.

Collaborations

Throughout her career, Francoise Roquet has collaborated with esteemed colleagues such as Michel Joannic and Marcel E Pesson. These collaborations have further enriched her research and development efforts.

Conclusion

Francoise Roquet's contributions to the field of pharmaceuticals demonstrate her commitment to innovation and improving health outcomes. Her work continues to have a lasting impact on the treatment of significant medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…